- Predictors of postoperative pancreatic fistula after splenectomy with or without distal pancreatectomy performed as a component of cytoreductive surgery for advanced ovarian cancer
-
Nishikimi K, Tate S, Matsuoka A, Otsuka S, Shozu M
- KMID: 2536992
- J Gynecol Oncol.
- 2022 May;33(3):e30.
- doi: 10.3802/jgo.2022.33.e30
Objective Splenectomy with or without distal pancreatectomy is occasionally performed during cytoreductive surgery for advanced ovarian cancer. We investigated pre-, intra-, postoperative risk factors and predictors of clinically relevant postoperative pancreatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgery
-
Utsumi M, Inagaki M, Kitada K, Tokunaga N, Kondo M, Sakurai Y, Yunoki K, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S
- KMID: 2532361
- Ann Surg Treat Res.
- 2022 Aug;103(2):72-80.
- doi: 10.4174/astr.2022.103.2.72
Purpose: This study was performed to determine the prognostic value of lymphocyte-to-CRP ratio after curative resection for hepatocellular carcinoma. Methods: Between July 2010 and October 2021, 173 consecutive patients (144 male,... -
- CITED
-
- Close
- SHARE
-
- Close
- Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial
-
Tate S, Nishikimi K, Matsuoka A, Otsuka S, Kato K, Takahashi Y, Shozu M
- KMID: 2526298
- J Gynecol Oncol.
- 2021 Jan;32(1):e8.
- doi: 10.3802/jgo.2021.32.e8
Objective: We investigated the efficacy and toxicity of tailored-dose chemotherapy with gemcitabine and irinotecan for platinum-refractory/resistant ovarian or primary peritoneal cancer. Methods: We enrolled patients with ovarian or primary peritoneal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
